Avatar

Swaraj Paul Barooah

.

Patent

MPP faces licensing issues


Image from Woody1778a We had earlier mentioned that the Medicines Patent Pool had gotten into an agreement with it’s first pharmaceutical company. However, it appears that there are certain problems with the licensing agreement, the interpretation and understanding of which is under dispute by two traditional heavyweights in this field. I-Mak released a briefing paper on the Implications of the MPP and Gilead licenses on Access to Treatment which addressed certain concerns that they had with the license; and Knowledge Ecology…


Read More »
Copyright

Fighting Piracy with Oppression?


Screenshot taken from TorrentFreak A frantic call from a friend last night informed me of a rather strange message on their screen. “This site has been blocked as per instructions from Department of Telecom (DoT)”. The site my friend was trying to access was Megaupload.com – an online storage site. A quick google inquiry brought up similar concerns being voiced by other internet users on internet forums. I, myself, however, was able to access the site with no problems. From…


Read More »
Innovation Patent

Gilead dips its toes into Patent Pool


Earlier this year, we had carried a post on UNITAID’s Medicines Patent Pool being in talks with several key pharmaceutical companies. In a press release by the Medicines Patent Pool today, they announced an agreement with Gilead Sciences, which makes them the first pharmaceutical company to join the MPP. Gilead also announced that they had already established license agreements with 4 India based drug manufacturers – Hetero Drugs Ltd., Matrix Laboratories Ltd., Ranbaxy Laboratories Ltd. and Strides Arcolab Ltd Patent Pools…


Read More »
Innovation

India ranks low on Innovation index


Image taken from here The ‘decade of innovation‘ 2011-2020, seems to have not taken off on a great start if the Global Innovation Index (GII) 2011 edition is anything to go by. The GII ranked India 62nd out of 125 economies measured for innovation levels, marking a continual decline since the Index started in 2009 – India was 56 in 2010, and 41 in 2009. Switzerland topped this year’s list followed by Sweden and Singapore, while China was the highest ‘lower-middle’…


Read More »

Internet Access is a Human Right declares UN Report!


The UN Special Rapporteur on the promotion and protection of the right to Freedom of Opinion and Expression, Frank La Rue, put forward a report to the UN Human Rights Council stating that internet access is a human right. Several current issues are addressed in the report. Emphasising the growing importance of internet in today’s society, the Special Rapporteur writes:  “Unlike any other medium, the Internet enables individuals to seek, receive and impart information and ideas of all kinds  instantaneously and…


Read More »
Patent

Patents do not hinder Access?


Recently, Mr. Ranjit Shahani, the president of Organisation of Pharmaceutical Producers of India (OPPI) and vice chairman and managing director of Novartis India, gave an interview to the Financial Express regarding the importance of patents to the pharmaceutical industry and its effects on access to medicines. I’d like to take this chance to react to his statements. I’ll be extracting certain excerpts but the full interview is available here (and it’s a quick read). Disclaimer: I’ll be focusing on the parts…


Read More »
Data Exclusivity

Anand Sharma gives a No to Data Exclusivity


Picture Credit: Kevin Dean from www.betaart.com As we’ve highlighted several times on this blog, the pharmaceutical lobby in EU and US have (through their governments) tried to push India into accepting many stronger IP rights, including data exclusivity. As we’ve also highlighted several times, data exclusivity has been consistently been opposed by the Indian Pharmaceutical Alliance as well as several NGOs; however we haven’t been as sure as to what position the government was going to take in the EU-India…


Read More »
Innovation

SpicyIP Tidbit: Google test pilots its Innovation Incubator program in SA


While Google may be facing criticism for trying to take too much power into their own hands with respect to their digitalisation of orphan works (see Amlan’s upcoming post for more on this), I doubt they will face any such opposition in their efforts to empower others by fostering innovation in Africa. Google has launched Umbono (Zulu for “idea/vision”) , a technological innovation incubator at Cape Town, South Africa. In a  statement from Google, they say: “For six months, teams will enjoy free office…


Read More »
Innovation Patent

Informing the pharma innovation debate: Harmonised IP standards and its effects


Image from here  [Since this is a more theoretical post, in the interests of our readers, I’m stating at the outset that this piece is essentially regarding policy questions that ought to arise while considering global drug innovation policies, either patents or otherwise. For the purposes of this post, I’m keeping the “access to medicines and drug innovation policy” debate as the context, and for purposes of convenience I am broadly dividing the parties in this debate into two sides…


Read More »
Data Exclusivity

March 2nd marks aggravated protests against FTA


While the government continues to march on with the EU-India FTA, protester’s have also continued to voice their concerns over the impact that the IP provisions of the draft Agreement will have on making medicines inaccessible. March 2nd marked a day of protest by health activists from across India including PLHIV Networks and Network of People who use Drugs, as well as activists from affected countries such as Nepal, Indonesia, Thailand and Philippines who came to New Delhi to voice their concerns…


Read More »